153 related articles for article (PubMed ID: 33418036)
1. Harnessing the therapeutic potential of antibodies targeting connexin hemichannels.
Buratto D; Donati V; Zonta F; Mammano F
Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166047. PubMed ID: 33418036
[TBL] [Abstract][Full Text] [Related]
2. Antibodies targeting extracellular domain of connexins for studies of hemichannels.
Riquelme MA; Kar R; Gu S; Jiang JX
Neuropharmacology; 2013 Dec; 75():525-32. PubMed ID: 23499293
[TBL] [Abstract][Full Text] [Related]
3. Emerging issues of connexin channels: biophysics fills the gap.
Harris AL
Q Rev Biophys; 2001 Aug; 34(3):325-472. PubMed ID: 11838236
[TBL] [Abstract][Full Text] [Related]
4. Design and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin Disorders.
Xu L; Carrer A; Zonta F; Qu Z; Ma P; Li S; Ceriani F; Buratto D; Crispino G; Zorzi V; Ziraldo G; Bruno F; Nardin C; Peres C; Mazzarda F; Salvatore AM; Raspa M; Scavizzi F; Chu Y; Xie S; Yang X; Liao J; Liu X; Wang W; Wang S; Yang G; Lerner RA; Mammano F
Front Mol Neurosci; 2017; 10():298. PubMed ID: 29018324
[No Abstract] [Full Text] [Related]
5. Perturbing plasma membrane hemichannels attenuates calcium signalling in cardiac cells and HeLa cells expressing connexins.
Verma V; Hallett MB; Leybaert L; Martin PE; Evans WH
Eur J Cell Biol; 2009 Feb; 88(2):79-90. PubMed ID: 18951659
[TBL] [Abstract][Full Text] [Related]
6. A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice.
Kuang Y; Zorzi V; Buratto D; Ziraldo G; Mazzarda F; Peres C; Nardin C; Salvatore AM; Chiani F; Scavizzi F; Raspa M; Qiang M; Chu Y; Shi X; Li Y; Liu L; Shi Y; Zonta F; Yang G; Lerner RA; Mammano F
EBioMedicine; 2020 Jul; 57():102825. PubMed ID: 32553574
[TBL] [Abstract][Full Text] [Related]
7. A Human-Derived Monoclonal Antibody Targeting Extracellular Connexin Domain Selectively Modulates Hemichannel Function.
Ziraldo G; Buratto D; Kuang Y; Xu L; Carrer A; Nardin C; Chiani F; Salvatore AM; Paludetti G; Lerner RA; Yang G; Zonta F; Mammano F
Front Physiol; 2019; 10():392. PubMed ID: 31263420
[TBL] [Abstract][Full Text] [Related]
8. Connexin hemichannel inhibition reduces acetaminophen-induced liver injury in mice.
Maes M; Crespo Yanguas S; Willebrords J; Weemhoff JL; da Silva TC; Decrock E; Lebofsky M; Pereira IVA; Leybaert L; Farhood A; Jaeschke H; Cogliati B; Vinken M
Toxicol Lett; 2017 Aug; 278():30-37. PubMed ID: 28687253
[TBL] [Abstract][Full Text] [Related]
9. Connexin hemichannel inhibitors with a focus on aminoglycosides.
Natha CM; Vemulapalli V; Fiori MC; Chang CT; Altenberg GA
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166115. PubMed ID: 33711451
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of connexin and pannexin channels as potential therapeutics.
Willebrords J; Maes M; Crespo Yanguas S; Vinken M
Pharmacol Ther; 2017 Dec; 180():144-160. PubMed ID: 28720428
[TBL] [Abstract][Full Text] [Related]
11. Regulation of connexin hemichannel activity by membrane potential and the extracellular calcium in health and disease.
Fasciani I; Temperán A; Pérez-Atencio LF; Escudero A; Martínez-Montero P; Molano J; Gómez-Hernández JM; Paino CL; González-Nieto D; Barrio LC
Neuropharmacology; 2013 Dec; 75():479-90. PubMed ID: 23587648
[TBL] [Abstract][Full Text] [Related]
12. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening.
Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L
Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825
[TBL] [Abstract][Full Text] [Related]
13. At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries.
Bol M; Wang N; De Bock M; Wacquier B; Decrock E; Gadicherla A; Decaluwé K; Vanheel B; van Rijen HV; Krysko DV; Bultynck G; Dupont G; Van de Voorde J; Leybaert L
Cardiovasc Res; 2017 Feb; 113(2):195-206. PubMed ID: 27677282
[TBL] [Abstract][Full Text] [Related]
14. Extracellular-loop peptide antibodies reveal a predominant hemichannel organization of connexins in polarized intestinal cells.
Clair C; Combettes L; Pierre F; Sansonetti P; Tran Van Nhieu G
Exp Cell Res; 2008 Apr; 314(6):1250-65. PubMed ID: 18267319
[TBL] [Abstract][Full Text] [Related]
15. A Simple Assay to Evaluate the Function of Human Connexin Hemichannels Expressed in Escherichia coli that Can Be Used for Drug Discovery and Mutant Analysis.
Fiori MC; Cuello LG; Altenberg GA
Curr Protoc Pharmacol; 2019 Dec; 87(1):e68. PubMed ID: 31756040
[TBL] [Abstract][Full Text] [Related]
16. The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response.
Rhett JM; Yeh ES
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29601539
[TBL] [Abstract][Full Text] [Related]
17. Hunting for connexin hemichannels.
Sáez JC; Leybaert L
FEBS Lett; 2014 Apr; 588(8):1205-11. PubMed ID: 24631534
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific phosphorylation-dependent regulation of connexin hemichannels.
Alstrøm JS; Hansen DB; Nielsen MS; MacAulay N
J Neurophysiol; 2015 Nov; 114(5):3014-22. PubMed ID: 26400258
[TBL] [Abstract][Full Text] [Related]
19. Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases.
Mat Nor MN; Rupenthal ID; Green CR; Acosta ML
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578721
[TBL] [Abstract][Full Text] [Related]
20. Connexins-Therapeutic Targets in Cancers.
Nalewajska M; Marchelek-Myśliwiec M; Opara-Bajerowicz M; Dziedziejko V; Pawlik A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
